Cancers | Free Full-Text | Pancreatic Cancer Chemoresistance to Gemcitabine | HTML
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? | British Journal of Cancer
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect
Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
Molecules | Free Full-Text | Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy | HTML
Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance
Overcoming tumor cell chemoresistance using nanoparticles: lysosomes a | IJN
IJMS | Free Full-Text | Chemoresistance in Pancreatic Cancer | HTML
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors | Pharmacogenomics
Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies
Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness
Promising molecular mechanisms responsible for gemcitabine resistance in cancer - ScienceDirect
Recent insights into the biology of pancreatic cancer - eBioMedicine
Gemcitabine Resistance in PDAC | Encyclopedia
Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation | Journal of Pharmacology and Experimental Therapeutics
Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma | Cancer Cell International | Full Text
GEMZAR® (gemcitabine) - Cancer Therapy Advisor
SciELO - Brasil - Carboplatin: molecular mechanisms of action associated with chemoresistance Carboplatin: molecular mechanisms of action associated with chemoresistance
Mechanism of action of gemcitabine 1 . | Download Scientific Diagram
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study | British Journal of Cancer
Mechanism of action of gemcitabine 1 . | Download Scientific Diagram
Gemcitabine Metabolism and Mechanism of Action
Metabolism of pancreatic cancer: paving the way to better anticancer strategies | Molecular Cancer | Full Text
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect
Oncology
Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines | Drug Metabolism & Disposition
Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance
